Results 31 to 40 of about 17,361 (234)

3-(5-Nitrofuran-2-yl)prop-2-en-1-one Derivatives, with Potent Antituberculosis Activity, Inhibit A Novel Therapeutic Target, Arylamine N-acetyltransferase, in Mycobacteria [PDF]

open access: yesAntibiotics, 2020
In this study, the inhibitory potential of 3-(5-nitrofuran-2-yl)prop-2-en-1-one derivatives was evaluated against a panel of bacteria, as well as mammalian cell lines to determine their therapeutic index.
Neha Agre   +6 more
doaj   +2 more sources

NAT2 (N-acetyltransferase 2 (arylamine N-acetyltransferase)) [PDF]

open access: greenAtlas of Genetics and Cytogenetics in Oncology and Haematology, 2011
Review on NAT2 (N-acetyltransferase 2 (arylamine N-acetyltransferase)), with data on DNA, on the protein encoded, and where the gene is implicated.
JD Ruiz   +3 more
openalex   +4 more sources

Piperidinols that show anti-tubercular activity as inhibitors of arylamine N-acetyltransferase: an essential enzyme for mycobacterial survival inside macrophages. [PDF]

open access: goldPLoS ONE, 2012
Latent M. tuberculosis infection presents one of the major obstacles in the global eradication of tuberculosis (TB). Cholesterol plays a critical role in the persistence of M. tuberculosis within the macrophage during latent infection.
Areej Abuhammad   +13 more
doaj   +3 more sources

NAT gene polymorphisms and susceptibility to Alzheimer's disease: identification of a novel NAT1 allelic variant

open access: yesBMC Medical Genetics, 2004
Background Alzheimer's disease is multifactorial, having environmental, toxicological and genetic risk factors. Impaired folate and homocysteine metabolism has been hypothesised to increase risk. In addition to its xenobiotic-metabolising capacity, human
Budge Marc   +4 more
doaj   +2 more sources

Effects of human arylamine N-acetyltransferase I knockdown in triple-negative breast cancer cell lines. [PDF]

open access: yesCancer Med, 2015
Expression of human arylamine N‐acetyltransferase I (NAT1) has been associated with various cancer subtypes and inhibition of this enzyme with small molecule inhibitors or siRNA affects cell growth and survival.
Tiang JM, Butcher NJ, Minchin RF.
europepmc   +2 more sources

Determination of Arylamine N-Acetyltransferase 2 Acetylation Genotype by PCR and Phenotyping Using Dapsone Through High-Pressure Liquid Chromatography Assay: A Gender Wise Study [PDF]

open access: yesDose-Response, 2019
The main aim of the study was to establish the acetylation status of local population of Pakistan by N-acetyltransferase 2 (NAT2) enzyme and to find out the concordance between phenotypic and genotypic methods for the determination of NAT2 acetylation ...
Naheed Akhter   +5 more
doaj   +2 more sources

Sheep Tissue Acetyl Coenzyme A-Dependent Arylamine N-Acetyltransferases

open access: greenComparative Biochemistry and Physiology Part C: Pharmacology, Toxicology and Endocrinology, 1997
Acetyl coenzyme A-dependent arylamine N-acetyltransferases (NATs), EC 2.3.1.5. were measured in sheep tissues (N = 14) using p-aminobenzoic acid (PABA) as a substrate. Specific activities of liver, kidney, and lung NATs were 5.3 x 10(-3) +/- 1.4 (mean +/- SE) nmoles.min-1.mg protein-1, 3.4 x 10(-3) +/- 1.1 nmoles.min-1.mg protein-1, 2.5 x 10(-3) +/- 1 ...
Tülïn Güray, Tolga Güvenç
openalex   +4 more sources

Correction to Subcellular Protein Labeling by a Spatially Restricted Arylamine N-Acetyltransferase. [PDF]

open access: hybridACS Chem Biol, 2019
Kleinpenning F   +5 more
europepmc   +3 more sources

Home - About - Disclaimer - Privacy